Amolyt Pharma Announces $80 Million Series B Financing led by Sectoral Asset Management and Andera Partners
Funds to be used to continue the clinical development of AZP-3601 for hypoparathyroidism while progressing AZP-3813 through IND-enabling activities in...
Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options